v1
Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.
Identifier:nobleid.org/w1/20260515/175ECB6B
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/175ECB6B)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims